Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Association of Lp-PLA(2) activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome.

Chae JS, Kim OY, Paik JK, Kang R, Seo WJ, Jeong TS, Sweeney G, Lee SH, Lee JH.

Atherosclerosis. 2011 Oct;218(2):499-506. doi: 10.1016/j.atherosclerosis.2011.06.036. Epub 2011 Jun 24.

PMID:
21762913
2.

Circulating and PBMC Lp-PLA2 associate differently with oxidative stress and subclinical inflammation in nonobese women (menopausal status).

Paik JK, Kim JY, Kim OY, Lee Y, Jeong TS, Sweeney G, Jang Y, Lee JH.

PLoS One. 2012;7(2):e29675. doi: 10.1371/journal.pone.0029675. Epub 2012 Feb 16.

4.

Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans.

Paik JK, Chae JS, Jang Y, Kim JY, Kim OY, Jeong TS, Lee SH, Lee JH.

Clin Chim Acta. 2010 Apr 2;411(7-8):486-93. doi: 10.1016/j.cca.2009.12.021. Epub 2010 Jan 18.

PMID:
20080080
5.

Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.

Kim JY, Hyun YJ, Jang Y, Lee BK, Chae JS, Kim SE, Yeo HY, Jeong TS, Jeon DW, Lee JH.

Am J Clin Nutr. 2008 Sep;88(3):630-7.

6.

Effect of age on atherogenicity of LDL and inflammatory markers in healthy women.

Paik JK, Chae JS, Kang R, Kwon N, Lee SH, Lee JH.

Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):967-72. doi: 10.1016/j.numecd.2012.08.002. Epub 2012 Sep 25.

PMID:
23021775
7.

The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.

Noto H, Chitkara P, Raskin P.

J Diabetes Complications. 2006 Nov-Dec;20(6):343-8.

PMID:
17070436
8.

Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.

Hirschler V, Meroño T, Maccallini G, Gomez Rosso L, Aranda C, Brites F.

Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):78-83.

PMID:
21476960
9.

Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome.

Kim OY, Paik JK, Lee JY, Lee SH, Lee JH.

Clin Exp Hypertens. 2013;35(5):382-8. doi: 10.3109/10641963.2012.739232. Epub 2012 Nov 13.

10.

Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids: Lp-LPA2 reduces oxidized fatty acids.

Rosenson RS, Vracar-Grabar M, Helenowski I.

Cardiovasc Drugs Ther. 2008 Feb;22(1):55-8. doi: 10.1007/s10557-008-6080-4. Epub 2008 Jan 23.

PMID:
18214661
11.

Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.

Dullaart RP, Constantinides A, Perton FG, van Leeuwen JJ, van Pelt JL, de Vries R, van Tol A.

J Clin Endocrinol Metab. 2011 Apr;96(4):1077-84. doi: 10.1210/jc.2010-2139. Epub 2011 Jan 20.

PMID:
21252249
12.

Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals.

Kim M, Paik JK, Kang R, Kim SY, Lee SH, Lee JH.

Metabolism. 2013 Apr;62(4):554-60. doi: 10.1016/j.metabol.2012.10.006. Epub 2012 Nov 9.

PMID:
23142163
13.

Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.

Onat A, Hergenç G, Can G, Uğur M, Nartop F.

Clin Chem Lab Med. 2011 Aug;49(8):1349-57. doi: 10.1515/CCLM.2011.110. Epub 2011 Jul 14.

PMID:
21756164
14.

Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes.

Morteza A, Nakhjavani M, Ghadiri-Anari A, Esteghamati A, Khalilzadeh O.

Eur Cytokine Netw. 2011 Jun;22(2):107-12. doi: 10.1684/ecn.2011.0282.

15.

[Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].

Jia ZR, Zhao D, Qi Y, Wang W, Wang M, Sun JY, Qin LP, Liu J.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Nov;41(11):962-7. Chinese.

PMID:
24370228
17.

Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.

Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD.

Clin Chem. 2005 Dec;51(12):2264-73. Epub 2005 Oct 13.

18.

Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women.

Lapointe A, Couillard C, Piché ME, Weisnagel SJ, Bergeron J, Nadeau A, Lemieux S.

Atherosclerosis. 2007 Apr;191(2):362-8. Epub 2006 May 4.

PMID:
16677652
19.

Oxidized low density lipoprotein and inflammation in gout patients.

Jiang X, Li M, Yang Q, Du L, Du J, Zhou J.

Cell Biochem Biophys. 2014 May;69(1):65-9. doi: 10.1007/s12013-013-9767-5.

20.

Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Gong HP, Du YM, Zhong LN, Dong ZQ, Wang X, Mao YJ, Lu QH.

Lipids Health Dis. 2011 Jan 19;10:13. doi: 10.1186/1476-511X-10-13.

Supplemental Content

Support Center